{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:46:25Z","timestamp":1783766785499,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05557-w","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T01:05:53Z","timestamp":1741827953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The long-term impact of single intraoperative instillation of pirarubicin after radical nephroureterectomy on local and systemic cancer control: a prospective, multicenter, randomized trial"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0989-359X","authenticated-orcid":false,"given":"Toru","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kanematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojun","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsushi","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"5557_CR1","unstructured":"EAU Guidelines Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6"},{"key":"5557_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O\u2019Brien","year":"2011","unstructured":"O\u2019Brien T, Ray E, Singh R et al (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60:703\u2013710. https:\/\/doi.org\/10.1016\/j.eururo.2011.05.064","journal-title":"Eur Urol"},{"key":"5557_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/iju.13054","volume":"23","author":"S Yamashita","year":"2016","unstructured":"Yamashita S, Ito A, Mitsuzuka K et al (2016) Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Int J Urol 23:378\u2013384. https:\/\/doi.org\/10.1111\/iju.13054","journal-title":"Int J Urol"},{"key":"5557_CR4","unstructured":"NCCN Clinical Practice Guidelines in (2023) Oncology (NCCN Guidelines\u00ae) Bladder Cancer Version 3.2023 \u2014 May 25"},{"key":"5557_CR5","doi-asserted-by":"publisher","unstructured":"Kenigsberg AP, Carpinito G, Gold SA et al (2022) Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: low but increasing utilization during minimally invasive nephroureterectomy. Urol Oncol 40. https:\/\/doi.org\/10.1016\/j.urolonc.2022.06.006.:452.e17-452.e23","DOI":"10.1016\/j.urolonc.2022.06.006"},{"key":"5557_CR6","doi-asserted-by":"publisher","first-page":"198e1","DOI":"10.1016\/j.clgc.2021.11.016","volume":"20","author":"F Del Giudice","year":"2022","unstructured":"Del Giudice F, van Uem S, Li S et al (2022) Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy in patients with upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: analysis of US claims on perioperative outcomes and health care costs. Clin Genitourin Cancer 20:198e1. 198.e9","journal-title":"Clin Genitourin Cancer"},{"key":"5557_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jjco\/hyw072","volume":"46","author":"E Kikuchi","year":"2016","unstructured":"Kikuchi E, Oya M (2016) Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan. Jpn J Clin Oncol 46:768\u2013774. https:\/\/doi.org\/10.1093\/jjco\/hyw072","journal-title":"Jpn J Clin Oncol"},{"key":"5557_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1046\/j.1442-2042.2001.00286.x","volume":"8","author":"N Sakamoto","year":"2001","unstructured":"Sakamoto N, Naito S, Kumazawa J et al (2001) Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study. Int J Urol 8:212\u2013216. https:\/\/doi.org\/10.1046\/j.1442-2042.2001.00286.x","journal-title":"Int J Urol"},{"key":"5557_CR9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","volume":"31","author":"A Ito","year":"2013","unstructured":"Ito A, Shintaku I, Satoh M et al (2013) Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP monotherapy study group trial. J Clin Oncol 31:1422\u20131427. https:\/\/doi.org\/10.1200\/JCO.2012.45.2128","journal-title":"J Clin Oncol"},{"key":"5557_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/bju.13935","volume":"120","author":"M Marchioni","year":"2017","unstructured":"Marchioni M, Primiceri G, Cindolo L et al (2017) Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int 120:313\u2013319. https:\/\/doi.org\/10.1111\/bju.13935","journal-title":"BJU Int"},{"key":"5557_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bju.14053","volume":"121","author":"RQ Guo","year":"2018","unstructured":"Guo RQ, Hong P, Xiong GY et al (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121:184\u2013193. https:\/\/doi.org\/10.1111\/bju.14053","journal-title":"BJU Int"},{"key":"5557_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000001929","volume":"206","author":"V Sharma","year":"2021","unstructured":"Sharma V, Miest TS, Juvet TS et al (2021) The impact of upper tract urothelial carcinoma diagnostic modality on intravesical recurrence after radical nephroureterectomy: A single institution series and updated Meta-Analysis. J Urol 206:558\u2013567. https:\/\/doi.org\/10.1097\/JU.0000000000001929","journal-title":"J Urol"},{"key":"5557_CR13","doi-asserted-by":"publisher","first-page":"1755368","DOI":"10.1155\/2022\/1755368","volume":"30","author":"B Fan","year":"2022","unstructured":"Fan B, Teng Q, Sun M et al (2022) Assessment of therapeutic benefit and option strategy on intravesical instillation for preventing bladder Cancer recurrence after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. J Oncol 30:1755368. https:\/\/doi.org\/10.1155\/2022\/1755368","journal-title":"J Oncol"},{"key":"5557_CR14","doi-asserted-by":"publisher","unstructured":"Lu DD, Boorjian SA, Raman JD (2017) Intravesical chemotherapy use after radical nephroureterectomy: A National survey of urologic oncologists. Urol Oncol 35.:113.e1-113.e7 https:\/\/doi.org\/10.1016\/j.urolonc.2016.10.016","DOI":"10.1016\/j.urolonc.2016.10.016"},{"key":"5557_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2020.10.003","volume":"22","author":"TR Dob\u00e9","year":"2020","unstructured":"Dob\u00e9 TR, Califano G, von Rundstedt FC et al (2020) Postoperative chemotherapy bladder instillation after radical nephroureterectomy: results of a European survey from the young academic urologist urothelial Cancer group. Eur Urol Open Sci 22:45\u201350. https:\/\/doi.org\/10.1016\/j.euros.2020.10.003","journal-title":"Eur Urol Open Sci"},{"key":"5557_CR16","doi-asserted-by":"publisher","unstructured":"Yoo SH, Jeong CW, Kwak C, Kim HH, Choo MS, Ku JH (2019) Intravesical chemotherapy after radical nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and network Meta-Analysis. J Clin Med 8;1059. https:\/\/doi.org\/10.3390\/jcm8071059","DOI":"10.3390\/jcm8071059"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05557-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05557-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05557-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:52:42Z","timestamp":1767966762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05557-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5557"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05557-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5391736\/v1","asserted-by":"object"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}